Skip to main content

Editorial team

Chief Editor: Rabia Begum

Rabia studied Biochemistry at Kings College London and received a PhD in neurogenetics from the MRC Prion Unit, UCL Institute of Neurology. Her doctoral research was focused on genetic modifiers of prion disease and mechanisms of disease susceptibility. Her research interests include neurogenomics, clinical genomics and precision medicine. She is based in the London office.

Locum Chief Editor: Roshan Ahmed

Roshan earned her Bachelor’s degree from the University of Chicago where she studied Biology and the History, Philosophy and Social Studies of Science and Medicine. She completed her doctoral research on pancreatic cancer metabolism and preclinical therapeutics at Columbia University and received her PhD in pharmacology and molecular signaling. Her research interests include cancer biology and the microbiome. She is based in the New York office.

Associate Editor: Patrik Flammer

Patrik holds an MSc in Molecular and Cell Biology, and completed his DPhil at the University of Oxford working on genetics and epidemiology of human intestinal parasites. His postdoctoral research extended this to include aspects of ancient DNA and epidemiology of infections in past populations. He is based in the London office.

Associate Editor: Gabriele Alfarano

Gabriele graduated in Medical Biotechnologies and Nanobiotechnologies at the University of Salento (Lecce, Italy). He obtained a PhD in Molecular Oncology at the European School of Molecular Medicine in Milan, working on the regulation of pancreatic cancer differentiation. He extended this work in his postdoctoral research to focus on the transcriptional, epigenetic and metabolic heterogeneity of pancreatic cancer. He is based in the Berlin office.

  • Editorial Board
  • Editorial Team
  • Call for EBMs
  • Call for papers
  • Sign up for article alerts and news from this journal
  • Manuscript editing services
  • Contact us
  • Announcements

    C19 Rapid Review initiative

    Genome Medicine has joined the C19 Rapid Review initiative, a cross-publisher collaboration to ensure that COVID-19 research is reviewed and published as quickly and openly as possible. Learn more here

    Submissions from medRxiv 

    Authors are now able to submit manuscripts to Genome Medicine directly from medRxiv without having to re-upload files.

    Portable peer review

    To reduce time spent on serial submissions and iterative reviewing, Genome Medicine offers to consider manuscripts on the basis of reviews received at other journals. We also support transfers of reviews obtained at Genome Medicine to other journals, including those outside of BMC and Springer Nature. Learn more from our peer review policy page.

    COVID-19 submissions

    In response to the current SARS-CoV-2 pandemic Genome Medicine editors will treat relevant submissions with high priority.

Annual Journal Metrics

  • 2022 Citation Impact
    12.3 - 2-year Impact Factor
    13.8 - 5-year Impact Factor
    2.422 - SNIP (Source Normalized Impact per Paper)
    4.851 - SJR (SCImago Journal Rank)

    2022 Speed
    64 days submission to first editorial decision for all manuscripts (Median)
    212 days submission to accept (Median)

    2022 Usage 
    14,220 Altmetric mentions